SUN-156 DNlite-IVD103, a novel urinary test, predicts progressive eGFR decline in type 2 diabetes with microalbuminuria

Diabetic kidney disease (DKD) is one of the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide. Despite being as a diagnostic criteria for DKD, the predictive value of urinary albumin-to-creatinine ratio (UACR) on the progression toward advanced CKD is limited, due to the heterogeneous disease nature. In this prospective cohort study, we evaluated the potential of a novel urinary test, DNlite-IVD103, for identifying progressive decliners of renal function in type 2 diabetes (T2DM) with microalbuminuria.